ISPOR 12th Annual European Congress Program Planning Committee |
| PROGRAM PLANNING COMMITTEE CHAIR |
 |
|
Claude Le Pen, PhD
Professor of Health Economics, University of Paris-Dauphine and Expert,
IMS Health, Puteaux, France |
|
| |
|
|
| RESEARCH REVIEW COMMITTEE CO-CHAIRS |
 |
|
Gérard de Pouvourville PhD
Professor & Chair of Health Economics, ESSEC, Cergy-Pontoise, France
|
 |
|
Andrew Lloyd DPhil
Director, Oxford Outcomes, Oxford, UK |
|
|
| WORKSHOP COMMITTEE CO-CHAIRS |
 |
|
Francis Fagnani PhD
Director, CEMKA-EVAL, Bourg la Reine, France
|
 |
|
Linus Jonsson PhD, MD, MSc
Vice President Health Economics & Outcomes, i3 Innovus, Stockholm, Sweden |
|
| |
|
|
| ISSUE PANEL COMMITTEE CO-CHAIRS |
 |
|
Lise Rochaix PhD
Professor, Economics Department, University of Aix-Marseille II, Marseilles, France |
 |
|
Jens Grueger PhD
Vice President, Head Global Market Access Primary Care, Pfizer Ltd., Tadworth, Surrey, UK |
|
|
| DECISION-MAKER CASE STUDY REVIEW COMMITTEE
CO-CHAIRS |
 |
|
Marie-Christine Woronoff-Lemsi PharmD, PhD
Professor, Hospital Pharmacist Doctor, CHU de Besançon, Jean Minjoz Hospital, Besançon, France
|
 |
|
Zbigniew J. Król MD, PhD
Public Affairs and Policy Director, Pfizer Poland, Warsaw, Poland (formerly Deputy Director for Health Technology Assessment, Agency for Health Technology Assessment – AHTAPol) |
|
| |
|
|
|